Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.
about
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patientsFungal allergy in asthma-state of the art and research needsRationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis protocolThe microbiome of the lungAs-yet-uncultivated oral bacteria: breadth and association with oral and extra-oral diseasesThe key role of genomics in modern vaccine and drug design for emerging infectious diseasesPyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected]The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementCulture enriched molecular profiling of the cystic fibrosis airway microbiomeChanges in cystic fibrosis airway microbial community associated with a severe decline in lung function.Mechanistic model of Rothia mucilaginosa adaptation toward persistence in the CF lung, based on a genome reconstructed from metagenomic dataUse of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humansThe role of the bacterial microbiome in lung diseaseIdentification of a siderophore utilization locus in nontypeable Haemophilus influenzaeEmergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions.Detection of plant DNA in the bronchoalveolar lavage of patients with ventilator-associated pneumonia.Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.Outbreak of Corynebacterium pseudodiphtheriticum infection in cystic fibrosis patients, France.Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genesReliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimensAntibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiThe changing microbial epidemiology in cystic fibrosis.Polymicrobial challenges to Koch's postulates: ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes.Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.Repertoire of intensive care unit pneumonia microbiotaTropheryma whipplei in patients with pneumoniaMolecular detection of eukaryotes in a single human stool sample from Senegal.Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities.Three clinically distinct chronic pediatric airway infections share a common core microbiotaThe adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbationsAnalysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions.MetaGeniE: characterizing human clinical samples using deep metagenomic sequencing.Determining the influence of environmental and patient specific factors on the polymicrobial communities of the cystic fibrosis airway.Clinical significance of microbial infection and adaptation in cystic fibrosis.Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.Phenotypic and genotypic properties of Microbacterium yannicii, a recently described multidrug resistant bacterium isolated from a lung transplanted patient with cystic fibrosis in France.Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbationsDolosigranulum pigrum keratitis: a three-case seriesHigh individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment.
P2860
Q21562196-A9FC14E5-6B83-4B79-AC39-ACB77D7F5AC5Q22001138-79DBDFEE-6B86-4FFD-8CB9-99D9056B845AQ23911842-2166257E-E27E-445C-AAB4-BEAEE9C921A7Q24602074-9B9F2E86-03D0-4122-B7ED-86BBE8239202Q24619768-850D3687-33B6-4953-8C53-BB0651077AA9Q28476274-ADBD7D5A-9005-444B-AD0E-1C4961F93B48Q28543599-158B01A0-4EDA-4BF2-8455-A731077149DCQ28730299-DC42F110-CDF8-4D32-A0C6-BC455AD49E56Q28742049-729DB65B-AA7D-43FA-8EE9-623EC05B456FQ30388877-8EE76BB3-B6F7-4ED4-9E9D-7A28064FC8D4Q30641042-3B74DD79-5DAA-40BE-B123-96FEC84A1370Q33388535-18A015C4-6185-4B85-8B5E-262D2990C91FQ33554623-BEE86B94-CABD-4F6A-A6B5-DE2FE8CB6D8DQ33557651-846FFFA9-FF8B-419C-AE27-CEE50DDBC8CBQ33609099-060AE30D-3E54-4550-89A0-1C552F4B075BQ33619114-75D1E9F9-E257-4D25-9237-62096B9A4E9AQ33633034-D2A40B0A-8BA5-4FAE-A9C9-972EC2C24050Q33647480-8B68B29C-A086-4C11-A1CF-C00DC5F6E4A0Q33743766-F61055B8-7B9A-45AC-B97E-273D94D32FC8Q33769617-96B4D3BF-7FF8-4D03-A94B-9ADE36430E43Q33770039-17D745A2-466F-4C73-A18C-7E54659C0901Q33792765-50289E3F-A3AE-4210-9B3C-FD0A5EF53A1BQ33825634-C1C87194-081F-4D61-A8ED-5F96E09D1773Q34179233-35F96082-A2F9-4A9F-8600-23278F58FDB5Q34181466-5B906B43-3161-4574-A253-1FAF04EBFF38Q34184581-55898AF6-FD4D-4967-9886-83A1EFD16363Q34216149-3AA8AB19-C5D6-48BF-AF86-F2B78AABB9BFQ34342492-5BFA2CE8-5859-4CE3-9DE5-45F85E56D6DAQ34404215-48718B9D-90E5-4748-9E85-00450ADDE6B5Q34425654-16E1AEB6-E790-4648-8DCA-FDAAADEF455EQ34437958-F6BB677A-BD6B-41EE-8816-DB5C8CBE271CQ34440993-59273ED6-3501-4578-96F2-4EA67278C3A1Q34445180-943B639E-2C08-457A-A09D-332EB4735ABDQ34488114-665029F8-F954-4B35-A307-745A9FEA8611Q34491552-1C14202F-9D9B-4D3A-BAF2-76A882665349Q34554419-8E85CC1F-6346-4990-AEF8-3D180A46256AQ34705295-D1C59AFD-9508-4EF6-B840-49C4BB736BBEQ34706914-5F2BCCFA-D197-4AA1-BEED-DE05D76F625CQ34810119-35DFD775-2D84-4888-8DE0-057B1F29D8A8Q35074619-41DE4346-C4B6-4D5F-B7B8-027F8FE4D5F7
P2860
Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Molecular detection of multipl ...... from cystic fibrosis patients.
@ast
Molecular detection of multipl ...... from cystic fibrosis patients.
@en
type
label
Molecular detection of multipl ...... from cystic fibrosis patients.
@ast
Molecular detection of multipl ...... from cystic fibrosis patients.
@en
prefLabel
Molecular detection of multipl ...... from cystic fibrosis patients.
@ast
Molecular detection of multipl ...... from cystic fibrosis patients.
@en
P2093
P2860
P50
P1433
P1476
Molecular detection of multipl ...... from cystic fibrosis patients.
@en
P2093
Hervé Richet
Jacques Sarles
Jean-Christophe Dubus
Martine Reynaud-Gaubert
Nathalie Stremler
P2860
P356
10.1371/JOURNAL.PONE.0002908
P407
P577
2008-08-06T00:00:00Z